title: Influence of fibrin glue on seroma formation after breast surgery.
abstract: BACKGROUND
  This study was designed to determine the effectiveness of Hemaseel APR fibrin sealant versus conventional drain placement in the prevention of seromas after breast procedures.
  
  
  METHODS
  A prospective, randomized, controlled study of subjects who were randomized into control (drain) and experimental (fibrin) groups was conducted.
  
  
  RESULTS
  Analysis of 82 patients showed similarly matched groups. Seroma formation rate was 45.5% in the control group and 36.8% in the fibrin glue group (P = 0.43). The rate of wound complications was similar. Aspirate volumes were significantly greater in the fibrin glue group. Drain placement saved patients >366 US dollars over fibrin glue.
  
  
  CONCLUSIONS
  Although use of fibrin sealant resulted in a nonsignificant decrease in seroma formation rate compared with that of drain placement, the higher cost involved, cumbersome technique, and higher aspirate volumes tend to indicate that there is no advantage to using fibrin glue over drain placement with the technique described.
authors.affiliation: Department of Surgery, University of Kansas School of Medicine-Wichita, Wichita, KS 67214, USA.
authors.forename: LyNette
authors.initials: L
authors.lastname: Johnson
authors.forename: Therése E
authors.initials: TE
authors.lastname: Cusick
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Helmer
authors.forename: Jacqueline S
authors.initials: JS
authors.lastname: Osland
mesh_terms: D000368:Aged; D001943:Breast Neoplasms / Q000473:pathology / Q000601:surgery*; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000191:economics / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008408:Mastectomy / Q000009:adverse effects*; D008875:Middle Aged; D011446:Prospective Studies; D021701:Sentinel Lymph Node Biopsy / Q000009:adverse effects*; D049291:Seroma / Q000209:etiology / Q000517:prevention & control*; D014014:Tissue Adhesives / Q000191:economics / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives